Introduction
Traditional immunoassays are conducted on sophisticated instruments by trained professionals in hospital or medical laboratories. The time from collecting samples to obtaining results usually require several days. For patients, the time lag might cause catastrophic consequences. Thus, easy-to-operate and low costs POC biosensor devices that could complete the detection everywhere, just as lateral flow tests, are in high demand. These devices are very useful for patients to know their health conditions on time and for doctors to make timely diagnosis. [1] REVIEW ' killer application' of microfluidics. [7] Even though the killer application has not realized yet, we strongly believe that such killer applications will appear in the near future.
Microfluidic chips can be fabricated using different materials, such as glass and silicon initially, paper and polymer in nowadays. [8] Some groundbreaking inventions such as polydimethylsiloxane (PDMS) pave the way for a broader application of microfluidics. There are many factors should be taken into consideration when selecting a material for microfluidics-based POC system: fabrication, integration, function, modification and cost. An ideal microfluidics-based immunoassays POC platform must be easily fabricated, highly integrated, low-cost and multifunctional. Materials largely affect some fundamental properties of microfluidic chips. Parameters important for the realization and performance of microfluidic immunoassays, such as optical properties, cost, chemical and physical properties of microfluidic chip are directly influenced by materials (including both materials identity and its fabrication). At the same time, the manufacture and chip assembly methods largely depends on the materials, which in turn have an effect on the properties of the chips.
This review focuses on the aspects of the recent advances in microfluidic-based immunoassays for POC diagnostics of biomarkers. We converge on the materials aspect of microfluidics immunoassays, including materials for microfluidic chips itself (fabrication, integration, function, modification and cost) and materials for improving the performance of the immunereaction (such as nanomaterials-modified antibody). We also review the state of the art in microfluidic POC immunoassay platforms, from the laboratory to routine clinical practice, and commercial products in the market. Finally, we discuss the current challenges and future developments in microfluidic immunoassays. Because there is already a number of very extensive reviews about lateral flow assays (LFA), [9] we have intentionally left these works out in this review.
Materials
In the early days of microfluidics, microfluidic chips typically compose of silicon and glass, as technology advances, other materials emerged, such as polymer, paper and others. Polymer-based materials often used in microfluidics comprise elastomers and thermoplastics, among them PDMS, polycarbonate (PC), poly (methyl methacrylate) (PMMA) are the most often used. Different from PDMS, thermoplastics can be fabricated by some well-developed industrial mass-production methods. Paper (or related polymeric material), a thin porous matrix produced by cellulose fibers, is an excellent material for wicking-based microfluidic devices. Microfluidic chip can also be fabricated by other materials, such as metals, [10] cotton, [11] bamboo [12] or cellophane. [13] Even though these materials are not yet broadly applied in immunoassays, they can be of great importance to the whole microfluidic field. Meanwhile, some novel and powerful materials for improving the performance of immunoassay are well developed, such as nanoparticles made of noble metal, quantum dots (QDs), upconversion nanoparticles and membrane-based materials. In this part, we compared the performance of different materials for fabricating microfluidics-based POC platforms. Their fabrication, integration, function, modification and cost are compared. Materials are often described in great detail. For more information, Table 1 lists and compares the bioanalytical performance of these following microfluidic immunoassays.Then material for improvement of immunoassay itself has also been examined.
Materials for Chip Fabrication

Elastomer
Elastomer can deform under weak stress and quickly restore to the original state owing to the low Young's modulus and high elastic. The most popular elastomer in microfluidics is PDMS. [29] The emergence of soft lithography makes PDMS have an unprecedented development in microfluidic field. [30] PDMS is highly elastic and easy to modify by oxygen plasma, which can paste two PDMS layers into structures such as enclosed channels, integrated valves and connected reservoirs. PDMS enables valves and pumps and many elements of fluidic control. It is also transparent to essentially the entire spectrum of visible light, allowing for optical readout. PDMS is non-toxic to most cells and permeable for oxygen and carbon dioxide transport, which can be advantageous for in cellular studies. [31] Microfluidic network for serial dilution combined with chaotic advective mixers (CAMs) can fabricate an immunoassay chip for analyzing multiple antibodies quantitatively in parallel 
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(3 of 20) 1601403 in small volumes (<1 µL) of liquids (Figure 1a) . [14] Samples of serum containing antibodies and BSA buffer injected to the chip by two inlets. And the microchannel network achieves serial dilution of analytes. The mixed sample then pass through the reaction channel and bound to the immobilized, second fluorescent antibody. Using a miniaturized detection systems, this platform can detection multiple HIV antibodies simultaneously.
By coating the primary antibody on the substrate in parallel, the remaining immune reactions are carried out in a vertical channel. This microfluidic channel-based immunoassays can quickly detect biomarkers with fewer reagents and faster time (Figure 1b) . [15] Using the vacuum methods to driven liquids, some vacuum-driven microfluidic platforms are invented. [32] The porous filter membrane sandwiched between two PDMS layers, vacuum power can accelerate the reaction (Figure 1c) . [16] This vacuum-accelerated microfluidic immunoassay (VAMI) chip can finish the whole experiment in 15 min. A similar chip allows the simultaneous detection of a searis of clinically important biomarkers at the same time. [17] Molecular logic gate can overcome the physical limitation of traditional silicon-based electronic system. [33] Combining the concept of logic gates with microfluidic immunoassays, a microfluidic bead-based immunoassays can perform logic operations for diagnosis (Figure 1d ). [18] The microfluidic immunoassay-based logic gates use tumor necrosis factor-α (TNF-α) cytokine and its antibody as the signal inputs and different functionalized polystyrene microbeads as the logic sensors. In this case, the logic gates are intended for use in decision making in diagnosis. This is an entirely new feature of such microfluidic immunoassays. [33, 18] The western blot (WB) is a widely used analytical technique in many fields ranging basic biology to medicine, and can detect specific proteins in a sample of cell/tissue homogenate or extract. We combines a microfluidic immunoassay with conventional protein blotting to develop a microfluidic western blot (µWB) (Figure 1e ). [19] To realize multiplexed blotting, a parallel, serpentine microfluidic channels chip can dramatically improve the WB system (Figure 1f) . [20] This multiplexed micro-blotting Figure 1 . PDMS-based microfluidics immunoassay chips. a) On-chip serial dilution and mixing for parallel analyzing multiple antigens. Reproduced with permission. [14] Copyright 2003, American Chemical Society. b) Microfluidic channel based immunoassays for biomarkers detection. Reproduced with permission. [15] Copyright 2016, RSC. c) Vacuum-accelerated microfluidic immunoassay direct assay for biomarkers detection. Reproduced with permission. [16] Copyright 2012, Springer. d) Logic gates integrated in microfluidics for decision making. Reproduced with permission. [18] Copyright 2015, Springer. e) Microfluidic western blot for multiple proteins analysis within one sample. Reproduced with permission. [19] Copyright 2010, American Chemical Society. f) Multiplexed microfluidic blotting of proteins and nucleic acids by parallel, serpentine microchannels. Reproduced with permission. [20] Microfluidic immunoassay can detect multiplex biomarkers simultaneous. However the low efficiency in the downstream data analysis still waste a lot of time. To tackle this problem, our group present a programming-based image processing method by analyzing signals in identified sub-array reaction zone (Figure 2a) . [34] Using this method, the image analysis can be finished in 5 minutes. However, in order to acquire data from the bioassays, the position of the region of interest (ROI) had to be manually defined. Inspired by two-dimensional (2D) barcodes, we developed a microfluidic network with build-in function patterns to analysis the signal obtained from microfluidic immunoassays (Figure 2b) . [35] The function patterns define the orientation and the area of the ROI, as well as the characteristic dimensions of the data elements in the 2D barcode. This allows hand-held scanners to automatically decode 2D barcodes, regardless of the orientation or size of the 2D image. To realize accurate and multiplexed biochemical assays in an even better way, we develop a barcoded microchips for biomolecular assays according to barcode symbology specification (Figure 2c ). [21] Using the barcode reader/smartphone, up to 20 samples can be detected simultaneous in a single barcoded chip.
Even through PDMS has enabled great progress for microfluidic devices, PDMS-based microfluidic devices have made little progress towards becoming real world products. For one thing, PDMS-based microfluidic devices usually need bulky control systems and other detection devices. The need for robust, cheap, small and reliable detector with very low power consumption still is a major hurdle in POC microfluidic immunoassays. For another, mass fabrication of PDMS-based chip is still a problem.
Glass and Silicon
The first generation of microfluidic chip use glass or silicon wafers as their chip fabrication materials utilizing micro-electromechanical systems technologies in a clean room. Despite high accuracy, this method usually requires sophisticated equipments, and not suitable for mass production. The tedious experimental fabrication procedure and the high cost are insurmountable obstacles when promoting it in many applications. Although the cost of chip fabrication is very high, glass and silicon are very reliable material when combining applications including on-chip reactions, droplet formation, capillary electrophoresis, and solvent extraction in certain extreme test conditions. An important class of microfluidics made with this materials is digital microfluidics (DMF). [36] Electrodes are patterned on glass or silicon wafers substrates. And the liquids can transfer by applying appropriate sequences of potentials to the corresponding electrodes, thereby realizing accurate operation of various liquids. As DMF can accurate and easily operate liquids, these devices have used in clinical testing, cell research, immunoassays and other biological applications. [36, 37] Integrating the cell culture, stimulation and immunocytochemistry, DMF can automatically conduct all of the experiments to quantitatively detection cell's signaling events in situ (Figure 3a) . [37a] First, thanks to the precise fluids control, this digital microfluidic immunocytochemistry in single Cells (DISC) can rapidly change solution concentration without high shear stress compared to flow-based microfluidic. This property ensure DISC can impose stimulation rapidly with high temporal resolution. To verify its performance, this DISC device test the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway. After stimulated the cell with platelet-derived growth factor (PDGF) in seconds, the antibody-based techniques can easily probe the cell responses. Second, this DISC device avoids the use of PDMSbased valves which are difficult to assemble and operate, and may promote the absorption of biomolecules onto the PDMS. This high temporal resolution and minimal substrate toxicity of DISC allow the study of new cell's signaling events.
Miniaturized immunoassays chips are driven by needs to detect and analyze individual cells, or only a small number of samples. A simple approach is further reducing the size of microfluidic channels to the nanoscale level, which some researchers have dubbed the "extended nanospace". Based on this concept, immunochemical reaction can conducts in a femtoliter volume space ( Figure 3b ). [22] Glass substrate are in high demand in that the liquid in nanochannel require high pressure to drive it and the fluorescent signal require optical transparency of the substrates when fabricating an extended nanofluidic channel. However, current glass-glass bonding methods usually need high temperature and are incompatibility with functionalization (particularly those that cannot withstand high temperatures). Using vacuum ultraviolet (VUV) light and low temperature bonding photolithographic technique for the patterning of antibody in extended nanochannels can settle this problem. This extended nanofluidic channel can detect biomarkers with higher sensitivity (LOD of 3 zmol (10 −21 mole)) and lower sample consumption (86 fL).
Due to the presence of non-specific adsorption, the remove of unbound reagents from the surface of the solid support is vital for enhancing sensitivity and selectivity for microfluidic immunoassays. A "supernatant separation" method utilized the magnetic forces to separate the unbounded antibodies is applicable to DMF for improving the washing performance ( Figure 3c ). [23] Unlike "serial dilution" method, this method applied magnetic field intermittently to achieve the aggregated and resuspended magnetic nanoparticles. After applying external magnetic field, the magnetic particles in the droplets gather around the magnetic field and the solution is sucked away. After the washing solution is added, the external magnetic field is released. Repeat this operation until finishing the cleaning procedure. This technique is useful for noncompetitive and competitive immunoassays and can reduce the consumption of reagent volumes and analysis time.
Although widely used in the laboratory, glass and silicon are not attractive in developing POC devices in industrial scales. The biggest obstacle comes from the high cost of chips fabrication. Compared to other materials, glass and silicon are hard to functionalize with biological molecules and valves are hard to achieve.
Paper
The commercial success of LFA, such as pregnancy tests and numerous other commercial strip tests, demonstrates that Reproduced with permission. [34] Copyright 2012, RSC. b) 2D barcodes inspired image analysis. Reproduced with permission. [35] Copyright 2013, AIP. c) Barcoded microchips for biomolecular assays. Reproduced with permission. [21] Copyright 2015, American Chemical Society.
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paper is a useful substrate in applications requiring low cost, flexible, disposable, user-friendly, rapid, robust, and adaptable to large-scale manufacturing chip fabrication material. [38] Paper, a thin porous matrix produced by cellulose fibers, is an excellent material for wicking-based devices. Typically, microfluidic paper-based analytical devices (µPADs) do not require external power owing to the capillary effect of hydrophilic channel and hydrophobic barriers. [39] However, these closed-channel devices based on wicking flow have some inevitable limitations in that cellulose fibers are partially filled in the channels.
To tackle this problem, some open-channel paper microfluidic devices have 'regular' microfluidic channel is created on paper by either engraving [40] folding, [41] embossing [42] or embossing cellophane methods. [13] These new microfluidic paper-based platforms can achieve many functions using in conventional PDMS channel-based microfluidics. On the one hand, µPADs can be fabricated by a variety of simple but useful printing techniques, such as wax printing, inkjet printing, flexographic printing, screen-printing and wax screen-printing, which make paper as an ideal substrate for POC diagnosis. [43] On the other Reproduced with permission. [22] c) Digital microfluidic utilized magnetic force for separating unbound antibodies in particle-based immunoassays. Reproduced with permission. [23] Copyright 2012, American Chemical Society.
hand, photolithography, stamping, paper cutting, origami, embossing, and even chemical modification methods can fabricate paper-based microfluidic chips. [9, 24] Because its industrial manufacturing process has long been optimized, it is one of the least expensive bulk manmade materials. These approaches hence provide some useful platforms for developing new POC diagnosis particularly using in resource-limited environments.
One distinctive feature of µPADs is patterned structure, which can easily integrate complex functionalized parts and allows precise manipulation of fluid flows. Since the solid phase of many paper-based immunoassays includes highly flammable material, patterning methods involving a temperature over 100 °C is not applicable. Here a new patterning method employs craft punch patterning (CPP) method to produce multiple test region (Figure 4a) . [25] Indirect-ELISA for mouse IgG detection through chemiluminescence and colorimetry can performed on the patterned paper, with a LOD as low as 267 amol and 26.7 fmol, respectively. Meanwhile, the multiple test region can not only conduct multiplex immunoassays, but also be available for recombinant immunoblot assay (RIBA) in one patterned paper. This was proved by the diagnosis of hepatitis C virus (HCV) infection.
Paper has a micro-porous structure with high specific area, which improves the immobilization of proteins and other biological agents. A simple miniaturized 56-microwell paper/ PMMA hybrid microfluidic enzyme linked immunosorbent assay (ELISA) microplate allow for rapid and high-throughput detection of infectious diseases (Figure 4b ). [44] When reagents are delivered and transferred through the 3D micro-porous paper in microwells of this hybrid microplate, antibody/antigen . Microfluidic paper-based analytical devices (µPADs), a) Craft punch patterning (CPP) patterning method at low temperature and chip diagnosis of hepatitis C virus infection. Reproduced with permission. [25] Copyright 2014, American Chemical Society. b) Paper/polymer hybrid microfluidic microplate for multiple disease biomarkers detection. Reproduced with permission. [44] Copyright 2016, NPG. c) The use of the excellent electrical conductivity properties of graphene and the large specific surface area of silica nanoparticles as a signal amplification strategy. Reproduced with permission. [45] Copyright 2013, American Chemical Society.
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Paper-based POC diagnostic devices still suffer from problems such as low throughput and semiquantitative detection. In general, diagnosis of disease in the early stage has a great significance for the care of patients. Thus it is necessary to develop methods for detecting biomarkers with improved sensitive and convenience. µPADs allowing for multiplexing and electrochemical sensing pave the way for rapid and inexpensive detection of diseases with improved precision and sensitivity. [46] Since the first appearance of paper electrochemical microfluidic chips, µPADs can conduct quantitative diagnostic biomarkers with high sensitivity, allowing the paper microfluidic chips have board applications areas. [26] Integrating the signal amplification methods on paper electrochemical microfluidic chip enables researches to use the excellent electrical conductivity properties of graphene and the large specific surface area of silica nanoparticles for improving the sensitivity of such assay (Figure 4c ). [45] Four kinds of cancer biomarkers: alpha-fetoprotein (AFP), CEA, cancer antigen 125 (CA125), and carbohydrate antigen 153 (CA153) are quantitatively analyzed simultaneously using this devices, which shows good stability, reproducibility, and accuracy with an LOD less than 10 pg. A rather straightforward and highly practical system can sensitively screen cystic fibrosis for newborns by electrodepositing copper nanoparticles on gold electrode for the improvement of signal and introducing magnetic nanoparticles as support for immune reaction. [47] To date, colorimetric methods are still widely used for the qualitative analysis of multiplex biomarkers on µPADs owing to its naked-eye readout. But the problem is that when determining the concentration of biomarkers, most colorimetric methods still require the use of an instrument. In POC diagnosis, complex and sophisticated instruments are not applicable. Colorimetric methods are limited to qualitative assay. It is difficult for quantitative testing. This problem may be the general problem of all the paper-based diagnostics technology, whether dipstick assays or LFAs. If researchers overcome these problems, µPADs will play an even broader role in many types of assays.
Thermoplastics
Different from PDMS, thermoplastics can be fabricated by some well-developed industrial mass-production methods. Many types of thermoplastics materials have become useful in designing POC chips. Typical thermoplastics for microfluidics chips include PC, PMMA, polyethylene terephthalate (PET) and polystyrene (PS). Compare to PDMS, these materials have better solvent compatibility, and more choices in bonding (i.e., can be bonded by thermobonding and glue-assisted bonding and ultrasound). Sophisticated microfluidic chip can realize using these materials. Centrifugal microfluidic platforms comprise a class of microfluidic chip that use thermoplastics as their chip fabrication materials. [48] Centrifugal microfluidic platforms can integrate many operation units by using the centrifugal force, Coriolis force, Euler force and extrinsic forces as their power. [27] Even though not yet industrialized, we believed that centrifugal microfluidics might eventually realize POC immunoassay.
Utilizing laser irradiated ferrowax microvalves (LIFM), the detection chambers can open or closed on-demand. This fully automated lab-on-a-disc with on-demand valves can achieve multiplex immunoassay (Figure 5a) . [28] This chip has two analyses units, each including sample separation, detection antibody, substrate, washing buffer, detection and waste chambers. Each unit has three reaction chambers contain different micro PS beads. This platform can detect biomarkers from 200 µm whole blood sample in 20 min with the same LOD and the dynamic range compared with conventional ELISA.
Due to the complexity of the blood sample and the shortage of detection biomarkers, detecting biomarkers from whole blood still need to be optimized. To tackle this problem, the capture bead can separate biomarkers from blood sample and enrich these biomarkers to ensure higher signal and lower LOD through sedimentation from density media (Figure 5b ). [49] First, the sample containing antigen is mixed with capture beads. Then, fluorescent antibody add in the mixture as the signal tag. Following incubation, the beads captured with antigen and florescent antibody are separated from the mixture. The fluorescent signal represents an index for determining the concentration of biomarkers.
CTCs are different from common cells on their size, morphology, density and membrane proteins. The detection and molecular characterization CTCs from whole blood in one assays are rare. A label-free cancer cells detection and characterization electrochemical centrifugal microfluidic platform are developed (Figure 5c ). [50] Gold electrode labeled anti-EpCAM antibody can capture the SKOV3 cancer cell. And the adsorption of cells changes the voltammetric response of the gold electrode which represents the existing of cancer cells. This platform can automatically conduct all the experiments requiring for separation and characterization cancer cells.
However, thermoplastics are often rigid and not permeable to gas, making these materials difficult to integrate with cell studies. While many advances in centrifugal microfluidic technology have been made, the full automation of this platform with reliable performance are still not available. The reason is that this manufacture method usually requires a set of molds which is suitable for mass production. Although chips massmanufactured in this way can have essentially the same properties, and there is economy associated with scale. The molds are expensive and time-consuming to make, such that they are not suitable for small scale prototyping.
Here we explain how to score the fabrication, integration, function, modification and cost of different materials. We compared the four types of materials in these five aspects one by one. For example, comparing the diversity and simplicity of chip fabrication, the order of choice of materials is paper, PDMS, other polymer, glass and silicon. The difference of these materials can be visualized in a radar diagram (Figure 6) . A detailed comparison of these four types of microfluidic materials are in PDMS are extensively adopted owing to their diverse modification methods and various functions. However, many microfluidic-based POC diagnostics chips require low cost and simple fabrication. In this respect, paper and thermoplastics are powerful candidates.
Materials for Enhanced Immunoassay
In some case, conventional ELISAs have a comparable poor sensitivity and selectivity owing to the complexity of samples and the insensitivity of the signal probes. The integration of nanomaterials and nanotechnology can enhance their performances. [51] Some novel and powerful materials for improving the performance of immunoassay are well developed, such as noble metal nanoparticles, QDs, upconversion particles and membrane-based materials. [52] Gold nanoparticles (AuNPs) are widely used in biochemical detection owing to their high biocompatibility and good optical properties. [53] AuNPs are easy to be functioned and can change their color when their surrounding environment change. Thus the combination of traditional ELISA and functionalized AuNPs can dramatically enhance of signals in the molecular level and expand their applications.
AuNPs can improve the efficiency of alkaline phosphatase (ALP)-based readout for immunoassays. ALP can remove Reproduced with permission. [28] Copyright 2012, American Chemical Society. b) Centrifugal microfluidic platform for ultrasensitive detection of botulinum toxin. Reproduced with permission. [49] Copyright 2015, American Chemical Society. c) A label-free electrochemical centrifugal microfluidic immunoassay platforms detection of ovarian cancer cells. Reproduced with permission. [50] Copyright 2015, ScienceDirect.
(11 of 20) 1601403 phosphate group from ascorbic acid-phosphate. The released ascorbic acid can reduce Cu 2+ to generate Cu(I) which triggers AuNPs aggregation by Cu(I)-catalyzed azide/alkyne cycloaddition (CuAAC) (Figure 7a) . [54] The LOD by naked-eye readout of Rabbit antihuman IgG is 80 ng/mL using CuAAC-mediated AuNP-based immunoassay, which is lower than the concentration of 1000 ng/mL in conventional ELISA for the visible readout. Serum samples from patients who suffered from Mycoplasma pneumonia (MP) infection was applied for this AuNPbased immunoassay. Using this CuAAC-mediated plasmonic nanosensor enables 100% naked-eye diagnosis of MP infection, which is better than the conventional para-nitrophenol phosphate-based ELISA (≈50%).
Our group developed a simple but powerful AuNP-based immunoassay by combining the CuAAC click reaction and visible color change upon AuNPs aggregation (Figure 7b) . [55] The enzyme on the secondary antibody are replaced by copper monoxide nanoparticle (CuO NP). After finishing the immunoreaction, the Cu 2+ was released into the solution by hydrochloric acids, which then was reduced by the added sodium ascorbate to mediate the CuAAC click reaction between azide-and alkyne-modified AuNPs. The click reaction initiated the aggregated of AnNPs thus resulting a red to blue color change. By optimizing the experimental conditions, anti-gp41 IgG was detected in whole serum at a concentration of 150 ng ml −1 with the naked eye readout.
Although CuAAC proves to be an elegant sensing platform, one limitation is that Cu(I) inhibits the enzymatic activity of HRP. [57] Thus, there is a pressing need to develop more powerful chemical strategies in developing HRP-triggered AuNP-based immunoassay biosensors. Iodide can catalyze the oxidation of cysteine to form cystine in the presence of H 2 O 2 . Due to the absence of free cysteine thiol groups and the increased steric hindrance, cystine is unable cause the aggregation of AuNPs. [58] However, in the present of HRP enzyme, Iodide can be oxided by H 2 O 2 to yield iodine, and the existing cysteine can trigger AuNPs aggregation by means of zwitterionic electrostatic interactions (Figure 7c ). [56] Based on this principle, we design an HRP-mediated, iodide-catalyzed cascade reaction that can modulate the dispersion/aggregation of AuNPs so as to achieve AuNP-based immunoassay. This AuNP-based immunoassay shows good specificity and allows naked-eye based readout in clinical diagnosis, which has great potential for biomedical diagnostics to improve the healthcare infrastructure in resource-constrained areas.
For heterogeneous systems, nonspecific adsorption can apparently reduce the performance of immunoassays. This may be the • Valves are difficult to realize • Not easy to assemble • Small size channels are not easy to realized biggest challenge in these microfluidic immunoassays. Difference substrates can significantly affect the state of immobilized proteins, and ultimately affect the sensitivity. [59] Electrospinning (ES) is a straightforward yet powerful method to fabricate membranes, which can improve the efficiency of immunoassay by promoting the adsorption of proteins. [60] We prepared a uniform PC fibers through ES method and then convert fibers into stable and flat membrane using a wet-press method for proteins immobilizing (Figure 8a,b) . [61] This porous fiber membrane can better promote the adsorption of IgG and lower the LOD compared to conventional types of membranes (Figure 8c,d) . PVDF porous membrane are made using the same method (Figure 8e ). [62] Comparing with the previous work, this electrospun (ES) nanofibrous PVDF membranes (ESPVDF) could be used in cross-array assay for detecting multiple pairs of antibodies.
The advanced nanoparticles and membranes-based materials greatly enhanced the performance of conventional immunoassays. AuNPs can be integrated in colorimetric assays owing to the clear color change when AuNPs become aggregated, which is useful for POC diagnosis especially for naked-eye readout. Membranes-based materials can increase the specific area for proteins immobilized, thus lower the LOD of immunoassays.
But how to integrate these nanoparticles-and membranesbased materials into the microfluidic immunoassays for POC diagnosis still remains a big problem. The stability of nanoparticles in long term storage and transportation is typically poor. In addition, it is difficult to guarantee that these materials have the same performance when integrated in microfluidic immunoassays for POC diagnosis as when they are used in traditional immunoassays. In addition, the safety of these materials for living environment is still unclear.
POC Diagnosis
POC diagnosis are emerged as a medical tests that diagnosis and treatment of the disease on site. Generally speaking POC demands that we carry out immunoassays in a small device autonomously, without resorting to any external equipment. Microfluidics-based immunoassays are emerging as powerful tools that meet these requirements. In this part, the state of the art in microfluidics immunoassays POC platforms are reviewed, from the laboratory to routine clinical practice, and even commercial products in the market. wet press' method to manufacture nanofibrous membranes. c) A schematic illustrating the immunoassay set-up. d) The enhanced performance of a surface-based immunoassay using the ESPC as an antibody-immobilization substrate. Reproduced with permission. [61] e) PVDF porous membrane used in cross-array assay for signal enhancement. Reproduced with permission. [62] www.advhealthmat.de
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Representative Reports from Academic Literature
Nano-biosensors based on localized-surface plasmon resonance (LSPR) with high sensitivity and anti-jamming properties have tremendous potential in POC diagnosis. [63] Integrating AuNPs into Microfluidic immunoassays chip allow the labelfree detection of biochemical events using LSPR (Figure 9a) . [64] AuNPs can be modified with probes, and targets can bind on the surface of AuNPs, thus changing the LSPR. This platform can change the loading units precisely thus ensure all the substrate can be measured. This platform can perform six detections simultaneously because of the integrated 6 channels. We measure anti-gp41 (a marker for HIV infection) antibodies of different concentrations with a label-free, simpler and faster way compared to traditional ELISA with this microfluidic system.
Toward the goal of creating "sensors that learn", researchers have developed programmable bio-nano-chip based on the bead sensor for multiplexed and multiclass chemical-and bio-sensing (Figure 9b ). [65] Typically, the plastic flow-through microchip integrated a 280 µm diameter porous agarose beads with analyte-specific antibodies which can specifically identify biomarkers. [66] The agarose beads allowed a higher density in capturing the biomarkers owing to the 3D lattice structure to result in higher signal than conventional approaches and, thus, improved sensitivity. The self-contained, integrated microchip was fabricated with plastic using injection method for massfabrication which are designed for POC diagnosis. Using the supplementary analyzer and automated data analysis software, biomarkers of prostate cancer, ovarian cancer, and acute myocardial infarction (AMI) are detected which demonstrated the bioassay flexibility. This group also developed a Cardiac ScoreCard that integrates statistical learning models that predict cardiovascular diseases which has the potential to alter the way we quantify our health.
Based on mechanically induced trapping of molecular interactions (MITOMI), a multiplexed digital-analog microfluidic immunoassay system can detect multiplex analytes with low LOD, high dynamic range, multiplexed biomarker analysis, and ultralow volume sample consumption (Figure 10a) . [67] This platform was characterized by single enzyme measurements, which can detect 10 fM green fluorescent protein (GFP) in buffer and 12 fM GFP in serum. Finally, integrated with a fluorescence USB microscope to enable diagnostic testing at home, or in resource limited field-environment, this platform can multiplex digital detection of anti-Ebola antibodies in serum at concentrations down to 1 pM.
Using microfluidics for replicating all steps of ELISA and nanoparticles for acquiring and enhancing signal, a POC microfluidic immunoassay chip was designed for the diagnosis (Figure 10b) . [68] This chip was fabricated by polystyrene and cyclic olefin copolymer. A bubble-based method can deliver 14 separate reagents, including sample, washing buffer, goldlabeled antibody and silver reagents solutions. Signal amplification was achieved by reducing silver ions onto nanoparticles. This chip can simultaneously diagnose HIV and syphilis within 20 min which had also been tested in Rwanda from hundreds human whole blood samples. An intelligent microscale electrochemical device (iMED) also use this "plug-in-cartridge" technology for multiple biomarkers detection within minutes. [70] After bonding screen-printed electrodes (SPEs) on PDMS surface, reagents can pass through the bonded SPE surface one by one. When modification of different reagents on the electrodes, this iMED can also rapidly detect multiple biomarkers in one assay within minutes.
Plasmonic lab-chip devices integrated with AuNPs can detect E. coli using surface plasmon resonance as signal (Figure 10c) . [69] A chip contains two PMMA layers assembled by a layer of double sided adhesive which integrated gold-coated substrate. The gold substrate was chemical modified with antibodies to capture pathogens. The change of local surface environment on AuNPs resulting a significant change of reflect light. The CMOS sensor can capture the change of reflected light which represents the concentration of pathogen. This Figure 10 . POC: Reports from academic literature. a) A multiplexed digital-analog microfluidic immunoassay system for multiplex analytes detection. Reproduced with permission. [67] Copyright 2016, American Chemical Society. b) Microfluidics-based diagnostics of HIV in the developing world with reliable performance. Reproduced with permission. [68] Copyright 2011, NPG. c) Label-free microfluidic immunoassay system using surface plasmon resonance (SPR) as signal output. Reproduced with permission. [69] Copyright 2015, NPG.
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Despite the growth of research interest in laboratory on POC diagnostics for improving global health, the successful cases achieving effective, reliable and affordable healthcare devices are rare. From the materials point of view, the properties of chip fabrication materials and the cost of the designed chip are sometimes in a bad match. In general, powerful laboratory microfluidic immunoassay platforms and POC portable analyzers have to cater to different areas of application in the past. But there are high demands for developing a POC platform that can detect biomarkers in the early stage of disease in recent years. As we demonstrated before, paper and thermoplastics are powerful candidates in developing POC devices from the perspective of cost and chip fabrication. However, these materials cannot meet the demands at detecting biomarkers in low concentration which are considered to be the golden opportunities in diagnosis and treatment of disease. To sum up, researchers need to develop new POC platforms in diagnosis of diseases at early stage, but existing materials make it hard to balance the demands between performance and cost. A careful choice of a number of different materials which exploit their advantages might be the way to the Holy Grail of miniaturized, automated, yet cost-effective POC immunoassays. If such assays exist, they will entirely change the faces of clinical diagnostics, quality control of food and beverage, drug discovery and basic research in life sciences.
Commercial Products
Many companies want to improve the performance of LFT because of the huge market behind, but without huge progress. [71] The aim is typically to improve the sensitivity of LFT and allow it to be suitable for quantitative immunoassay, just like ELISA, but it is difficult to achieve these goals without sacrificing the simplicity of operation for LFT. While only a few kinds of microfluidic immunoassay platforms have so far commercialized successfully, LOC-based methods are still the most likely to change the entire diagnostic industry. The main reason lies in that microfluidics can potentially meet all the requirements of POC diagnosis. Microfluidics can precisely manipulate small amount of liquids, typically in sub-millimeter scale, thus lowering reagents consumption and shortening assay time. Meanwhile, microfluidics can integrate different functions in a single chip, resulting in detecting multiple biomarkers in complex bio-samples. Many different platforms employ microfluidics and immunoassays to detect and diagnose diseases. A detailed review has described successfully commercialized products in POC diagnostics applications before 2011 and presented some challenges and lessons according to their personal experiences with Claros Diagnostics. [71] The Whitesides group has also shared their two experiences on how to diagnosis disease in rural areas and how to evaluate chip performance under real world. [72] There are other kinds of publications that guide innovators to commercialize their microfluidic POC systems. [73] Table 3 lists some representative systems and compares their performance. [74] Their images are in Figure 11 . It should be noted that most of them are made from plastic, and are commercially available.
Gyrolab Bioaffy CD exploit microfluidics realize fluorescence-based sandwich ELISA using capillary action and centrifugal forces for automatically performing all the steps requires for ELISA on chip (Figure 11d) . MNCHIP Technologies Co., Ltd had also developed a Pointcare M platform that can automatically detection several biomarkers in 10 min using about 100 µl of whole blood (lithium-heparinized), plasma (lithiumheparinized) or serum sample (Figure 11h ). Pointcare M chips are conveniently packaged as single-use reagent discs. Each reagent disc has different functions depending on the contained reagents to perform a complete multi-chemistry blood analysis. Samsung automatic immunoassay analyzer LABGEO IB10 can quickly perform various tests with simple, easy processes, and precise results to improve patient care (Figure 11i) . Only by injecting 500 µL plasma, the results will be presented in 30 minutes. Our group has worked with a Beijing-based company (NanoAce) to commercialize microfluidic immunoassays and the first line of products has won approval by the Chinese Food and Drug Administration for clinical use (Figure 11j,k) . NanoAce is also applying microfluidic immunoassays for quality control in food and beverages. The biochip reader NanoAce 1010P can highly sensitively capture chemiluminescence signals, which is applied to semi-automatic biomarkers detection. The fully automatic biochip reader NanoAce 1024A can automatically detect biomarkers from sample loading to result printing. Both of them are available in the market.
Challenges and Opportunities
In order to combat and diagnose infectious diseases in developing countries, the WHO recommends that diagnostics for the developing countries should fulfill the following criteria: (i) affordable, (ii) sensitive, (iii) specific, (iv) user-friendly, (v) rapid and robust, (vi) equipment-free and (vii) deliverable to end-users, or ASSURED. [75] In this aspect, microfluidic POC diagnosis platforms are the best candidates. Apart from immunoassays, nucleic acid amplification assays and other molecular assays are often used methods integrated in microfluidic platform for detecting nucleic acids, proteins, pathogens Copyright 2017, MNCHIP. g) NanoAce 1010P from Nano Ace. Reproduced with permission. [74g] Copyright 2017, Nano Ace h) NanoAce 1024A from Nano Ace. Reproduced with permission. [74g] Copyright 2017, Nano Ace.
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Adv. Healthcare Mater. 2017, 6, 1601403 www.advancedsciencenews.com and cells. [76] Despite the unique advantages offered by microfluidic platforms, significant challenges lie ahead for the successful and full integration of such systems in routine clinical and POC diagnosis. As we described before, the properties of chip fabrication materials and the cost of the designed chip are sometimes in a poor match. Some of the other challenges are outlined in the following aspects.
Integration: Integrating microfluidic disposables and their associated instrumentation into a complete analytical platform is a primary task for POC diagnostics. In the early years, driven by the concept of "micro-total analysis system", a series of analytical chemical operation have been achieved. A fully integrated POC platform includes surface modification and immobilization, sample pre-treatment, reagent transportation, signal acquisition, and data analysis. Each components and procedures are well developed, but how to combine individual components into an integrated system may not as easy as it seems. Meanwhile, robust, inexpensive, small and reliable detector with very low power consumption still is a major hurdle in POC microfluidic immunoassays. PDMS-based microfluidic devices usually need bulky control systems and other detection devices. Paper colorimetric methods are limited to qualitative assays with low requirements for sensitivity. This limitation may be a huge obstacle preventing the application of this technology in life. Thus, development of instrumentation/detection methods is also quite important.
Chip fabrication and assembly: Choosing the right material is the first and usually a crucial step for a microfluidic chip, but the standards for choosing the material may change regarding different applications. For laboratory use, polymers especially PDMS are extensively adopted owing to their diverse modification methods and various functions. However, for POC applications, low cost and simple fabrication mass-production methods would be needed. Plastic can be produced by lamination, embossing, or injection molding method and paper can be produced by printing techniques for mass-production. They are two leading materials in developing POC devices. The precision of 3D printing have reached to micro-or even nano-level. This technology can quickly manufacture microfluidic chip with higher accuracy and lower materials consumption. [77] Some even predicte that 3D printing can eventually replace most of the current chip manufacturing technology, and will have even broader applications. [78] Sensitivity, selectivity and stability: Sensitivity and selectivity are important for the immunoassays chips. The problems are sensitivity and selectivity must meet the demands of the peculiar application. Higher sensitivity and better selectivity typically increase the cost, but in certain applications it is not necessary to have such high sensitivity or selectivity. POC diagnosis devices have to withstand the challenges from complex environments and poor medical conditions. Stability might be the greatest issues, intra/inter batch differences of assay results ideally need to be below 5%, which is typically difficult to achieve.
Reagent storage: A highly integrated microfluidic system usually requires that we only need to add small amounts of biological sample from patients in whole experiment. This requires we should preassemble all related reagents on chip. Reagent storage, especially low concentrations of reagents often require low temperature and professional preservation conditions. Even so, reagents can not be stored for a long time. Not to mention low temperature or refrigeration is unrealistic in resource-poor settings. The application of immunoassays will be dramatically broadened when this problem can be resolved.
Marketing and funding: Fundraising is a prerequisite in bringing a promising technology to the market. The hotspot global issues comprise a growing albeit nontraditional market, i.e., developing POC devices for developing countries may not work with accepted business models for maximization of the return in investment. Utilizing cheap smartphones and/or functionally equivalent devices as part of the diagnostic system might lower the cost to allow broad use. [72b,79] 
Conclusion and Future Perspectives
Microfluidic immunoassays possess remarkable features that surpass those of conventional immunoassay systems. These features include reduced consumption of reagents and samples, operational automation, cheap unit cost, low power consumption, and compact size. Moreover, the high surface-to-volume ratio of microfluidic immunoassays can enhance mass transport, resulting in shorter assay times and greater reliability. But there still exists some problem to solve, such as fabrication materials, packaging method, purification/concentration, and reagent storage. Many of these challenges fall within the expertise of materials scientists. We thus would like to call on all materials scientists to look at these problems -some of them may already have answers in their toolkits, without fully realizing the potential of their tools in resolving these tough problems. If all these problems are considered and well settled in developing microfluidic immunoassay chips, we believed that the true POC immunoassay well be the 'killer application' of microfluidics. Many fields, such as fundament biological research, pharmaceutical screening/evaluation, clinical diagnostics, quality control of food and beverages, might be fundamentally altered as a result of such killer applications.
